MENU
CYCC
Stock ticker: NASDAQ
PRICE
CHANGE
CAPITALIZATION
Cyclacel Pharmaceuticals (CYCC) Ownership - Who owns Cyclacel Pharmaceuticals?
Cyclacel Pharmaceuticals Inc is a clinical-stage biopharmaceutical company that develops targeted medicines for cancer and other proliferative diseases... Show more
Industry: #Biotechnology
Profile
Industry
Biotechnology
Address
200 Connell Drive
Phone
+1 908 517-7330
Employees
12
Web
https://cyclacel.com
Details
Group
Domestic Stock Funds
Category
Biotechnology
Capitalization
34.45M
P/E Ratio
0.50
Total Cash
93K
Projected Growth
N/A
Total Debt
N/A
Revenue
43K
Risk (Beta)
N/A
Dividend Yield
N/A
Total Cash/Share
0.00
Total Debt/Equity
N/A
Revenue/Share
0.00 USD as % of share price
Fundamentals
CYCC
Capitalization
34.5M
P/E Ratio
0.50
Risk (Beta)
N/A
Dividend Yield
N/A
Total Cash
93K
Total Cash/Share
0.00
Total Debt
0
Total Debt/Equity
N/A
Projected Growth (PEG Ratio)
N/A
Revenue/Share (as % of the share price)
0.00%
Revenue
43K
ROE
N/A
Book Value
-2.17M
P/B Ratio
11.25
Cash Flow
N/A
Earnings
-33.44
Average Daily Volume YTD
N/A
Common Shares Outstanding - Security Level
9K
Current Ratio
0.59
Current Revenue Per Employee
10714.29
Dividends Per Share - Security
N/A
EBITDA
-12M
Float
N/A
Float - Current
N/A
Gross Income Margin
100.00
Revenue To Assets
-173.84
Shares Held By Institutions
N/A
Shares Outstanding - Current
23.8M
Total Liabilities
6.27M
Total Volume MTD
N/A
Value
-1
Gain YTD
-75.898
View a ticker or compare two or three
VS
VS
Show more...
Interact to see
Advertisement
Advertisement
A.I.Advisor
published price charts
A.I. Advisor
published General Information
General Information
a developer of mechanism-targeted drugs to treat human cancers
Industry Biotechnology
Profile
Fundamentals
Details
Industry
Biotechnology
Address
200 Connell Drive
Phone
+1 908 517-7330
Employees
12
Web
https://cyclacel.com